Share

CLINICAL TRIAL SEARCH RESULTS

NEW SEARCH
 Number: 201407160 Principal Investigator: Carson, Kenneth
Title: A multicenter phase I dose-finding and preliminary efficacy study of the histone deacetylase inhibitor romidepsin (Istodax) in combination with gemcitabine (Gemzar), oxaliplatin (Eloxatin), and dexamethasone for the treatment of adults with relapsed/refractory aggressive lymphomas
Description: The purpose of this research study is to find the maximum tolerated dose of a drug called romidepsin when given with a treatment regimen called GemOxD. GemOxD is a routine treatment for your type of lymphoma, and involves the administration of three drugs: gemcitabine, oxaliplatin, and dexamethasone...MORE
___________________________________________________________________________________________________
 Number: 201010719 Principal Investigator: Fehniger, Todd
Title: A Pilot Study of Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplantation in Patients with Relapsed/Refractory Hodgkin Lymphoma
Description: The purpose of this research study is to gather information about lenalidomide maintenance therapy in patients with classical Hodgkin lymphoma....MORE
___________________________________________________________________________________________________
 Number: CALGB 50801 Principal Investigator: Bartlett, Nancy
Title: Phase II Trial of Response-Adapted Therapy Based on Position Emission Tomography (PET) for Bulky Stage I and Stage II Classical Hodgkin Lymphoma (HL)
Description: The purpose of this study is to find out if we can safely reduce the total number of cycles of chemotherapy that patients will need for their Hodgkin lymphoma based on their response during treatment as seen on positron emission tomography (PET) scan images. This research is being done in order ...MORE
___________________________________________________________________________________________________
 Number: 201210128 Principal Investigator: Bartlett, Nancy
Title: A Randomized, Open-label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma (C25003)
Description: The purpose of this research study is to compare how well two different treatments work. In this study, patients will receive either a treatment that includes the investigational drug called brentuximab vedotin or a commonly prescribed treatment that does not contain brentuximab vedotin....MORE
___________________________________________________________________________________________________